These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28761264)

  • 1. A Case Report of Verruca Vulgaris on basis of Alopecia Areata Successfully Treated with Diphenylcyclopropenone.
    Uzuncakmak TK; Koska MC; Karadağ AS; Akdeniz N
    Int J Trichology; 2017; 9(1):35-37. PubMed ID: 28761264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population.
    Aghaei S
    BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
    Brown L; Skopit S
    J Drugs Dermatol; 2018 Aug; 17(8):914-917. PubMed ID: 30124734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
    Shapiro J; Tan J; Ho V; Abbott F; Tron V
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):729-35. PubMed ID: 7901248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series.
    Durdu M; Özcan D; Baba M; Seçkin D
    J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
    Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
    Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive scalp angioedema following high-dose diphenylcyclopropenone for alopecia areata.
    Buchanan R; Huynh G; Tanner J
    Hosp Pharm; 2014 Jan; 49(1):48-51. PubMed ID: 24421563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monotherapy for Alopecia Areata: A Systematic Review and Network Meta-Analysis.
    Gupta AK; Carviel JL; Foley KA; Shear NH; Piraccini BM; Piguet V; Tosti A
    Skin Appendage Disord; 2019 Nov; 5(6):331-337. PubMed ID: 31799258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the severity of initial sensitization to diphenylcyclopropenone in alopecia areata patients predictive of the final clinical response?
    Ghandi N; Seifi G; Nasimi M; Abedini R; Mirabedian S; Etesami I; Ehsani A
    Dermatol Ther; 2021 Nov; 34(6):e15118. PubMed ID: 34464020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Treatment with Topical Diphenylcyclopropenone for Three Cases of Anogenital Warts in Children.
    Miyata K; Go U; Fujita M; Mitsuishi T
    Case Rep Dermatol; 2019; 11(2):123-129. PubMed ID: 31182946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphenylcyclopropenone and platelet-rich plasma in the management of severe or recalcitrant alopecia areata.
    Abd El-Magid WM; Mohamed RA; Elsharkawy RE
    J Cosmet Dermatol; 2023 Nov; 22(11):2971-2981. PubMed ID: 37313640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the Cytokine Analysis of the Scales on Alopecic Patch Predict the Response to Diphenylcyclopropenone Treatment in Alopecia Areata Patients?
    Lee SH; Moon JH; Ban DH; Byun JW; Shin J; Choi GS
    Ann Dermatol; 2018 Apr; 30(2):150-157. PubMed ID: 29606811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
    Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
    J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases.
    Choe SJ; Lee S; Pi LQ; Keum DI; Lee CH; Kim BJ; Lee WS
    J Am Acad Dermatol; 2018 Mar; 78(3):515-521.e4. PubMed ID: 29108907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S; Kim BJ; Lee YB; Lee WS
    JAMA Dermatol; 2018 Oct; 154(10):1145-1151. PubMed ID: 30073292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata.
    Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F
    Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA).
    Galadari I; Rubaie S; Alkaabi J; Galadari H
    Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
    Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience.
    El Khoury J; Abd-el-Baki J; Succariah F; Abbas O; Kibbi AG; Kurban M
    Int J Dermatol; 2013 Dec; 52(12):1551-6. PubMed ID: 24134785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.